12:00 AM
 | 
Feb 04, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Keryx completes follow-on

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), New York, N.Y.
Business: Endocrine/Metabolic, Cancer
Date completed: 1/30/13
Type:...

Read the full 50 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >